We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Devastating Neurological Disorder Caused by Single Gene Mutation

By Biotechdaily staff writers
Posted on 16 Jun 2008
A new study has shown that the single gene mutation responsible for Rett syndrome ultimately affects the function of more than 2500 other genes.

Rett syndrome has a distinctive onset and course. More...
The affected child—almost always a girl—develops normally during the first five months of life. After the fifth month, head growth slows down and the child loses whatever purposeful hand movements she had developed during her first five months. After 30 months, the child frequently develops repetitive hand washing or hand wringing gestures; 50–80% of children with the disorder will eventually have seizures. Rett syndrome is also associated with varying degrees of mental retardation.

Rett syndrome is caused by the failure of the infant's brain to develop normally. This developmental failure is in turn associated with a mutation in the MECP2 gene, which resides on the far end of the longest arm of the X chromosome.

After failing to establish a cause and effect relationship between the MECP2 mutation and the large variety of symptoms displayed by Rett syndrome victims by studying overall gene function in the brain, investigators at Baylor College of Medicine (Houston, TX, USA) decided to focus their attention on the hypothalamus region of the brains of laboratory mice. They studied both Rett syndromes, where MECP2 fails to function, and a newly identified mutation where MECP2 is duplicated and its protein product overexpressed.

Results published in the May 30, 2008, issue of the journal Science revealed that both disorders changed the expression of about 2,500 genes. In the animals with Rett syndrome, 2,200 genes were less active than they were in normal mice, while the remainder showed increased activity. The numbers were precisely reversed in the duplication syndrome.

"From a practical viewpoint, knowing how the two syndromes behave on a molecular level is really important,” said senior author Dr. Huda Zoghbi, professor of molecular genetics at Baylor College of Medicine. "The duplication syndrome and Rett syndrome may share many clinical symptoms, but on the level of the neuron they are totally different, and so the treatment would be totally different.”

"Rett syndrome is a devastating disease,” said Dr. Zoghbi. "Think about what it takes to function normally: You have to be coordinated, you must be able to think, you have to be able to communicate, and you need to move smoothly and with balance. The symptoms of other neurological diseases affect some of these functions, but Rett syndrome affects them all. Rett syndrome is particularly heartbreaking, because it develops after the child has already learned to walk, and perhaps even say a few words. To lose all that, and gradually develop a symptom from almost every neurological disease in the book is quite mind-boggling.”


Related Links:
Baylor College of Medicine

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.